Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
7259390 | Addictive Behaviors | 2018 | 5 Pages |
Abstract
The addition of a 2nd generation EC to outpatient tobacco treatment among tobacco smokers is feasible. Among those who quit smoking, half were still using the EC at 6-month follow-up. Appeal of the EC among smokers was variable, and those who had quit smoking tended to switch to lower strength nicotine solutions. Further research is needed to determine whether ECs can reduce harm and be an effective adjunct to existing tobacco treatment interventions.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Stephen R. Baldassarri, Steven L. Bernstein, Geoffrey L. Chupp, Martin D. Slade, Lisa M. Fucito, Benjamin A. Toll,